Next |
home / stock / trypf / trypf message board
Subject | By | Source | When |
---|---|---|---|
New $TRYP CEO interview: https://youtu.be/VZWvVG686bgNext Wav | Investopotia | investorshub | 02/01/2022 3:18:43 PM |
Ran with a profit. LOL. It's been | Bruinfan4ever | investorshub | 01/24/2022 4:42:24 PM |
Don't care because l took my money and | 49andretired | investorshub | 01/24/2022 4:27:53 PM |
This thing is going to a penny. So sad. | Bruinfan4ever | investorshub | 01/24/2022 4:23:00 PM |
Well said :) | MADDSTACKER | investorshub | 01/20/2022 1:51:22 PM |
It looks like around 3.25 mil cash available | Maverick75 | investorshub | 01/15/2022 3:54:51 PM |
Does anyone know how much cash they have ? | MADDSTACKER | investorshub | 01/13/2022 6:55:53 PM |
Grabbed 5k shares glta | MADDSTACKER | investorshub | 12/22/2021 6:21:01 PM |
Gonna be a big mover soon! | MyBuster1966 | investorshub | 11/07/2021 3:05:36 AM |
Rumor is we are move to a new | 49andretired | investorshub | 10/14/2021 12:24:57 PM |
49andretired | investorshub | 10/07/2021 12:50:41 PM | |
Tryp Therapeutics Announces Collaboration with Researchers at the | 49andretired | investorshub | 10/07/2021 12:49:17 PM |
some volume coming in past couple days..good to | vegasandre | investorshub | 07/28/2021 6:27:25 PM |
Tryp Therapeutics Appoints Robin Carhart-Harris, Ph.D. as SAB | vegasandre | investorshub | 07/27/2021 6:28:08 PM |
Tryp Therapeutics Announces Phase 2a Clinical Trial for | vegasandre | investorshub | 07/21/2021 2:38:06 PM |
I have easily bought shares on etrade and | vegasandre | investorshub | 07/08/2021 7:00:40 PM |
Actually my trade did not go through, apparently | Frenchy2016 | investorshub | 07/08/2021 6:49:21 PM |
Tryp Therapeutics Partners with the University of Michigan | vegasandre | investorshub | 07/08/2021 6:35:23 PM |
Hi Frenchy same here! | vegasandre | investorshub | 07/08/2021 6:34:26 PM |
Just wanna say Hi!! | Frenchy2016 | investorshub | 06/29/2021 2:03:43 PM |
News, Short Squeeze, Breakout and More Instantly...
Tryp Therapeutics Inc Com Company Name:
TRYPF Stock Symbol:
OTCMKTS Market:
Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) , a pioneering clinical-stage biotechnology company focused on developing intravenous-infused psilocin (the active metabolite of psilocybin) for diseases with high unmet medical needs, announced that company shareholders approved an announced arrangeme...
KELOWNA, BC / ACCESSWIRE / March 12, 2024 / Tryp Therapeutics, Inc. (" Tryp " or the " Company ") ( CSE:TRYP)(OTCQB:TRYPF ) is pleased to announce that the Company's securityholders overwhelmingly approved the previously announced arrangement (the " Arrangement ") involving the Company and Exoph...
Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) , a pioneering clinical-stage biotechnology company focused on developing intravenous-infused psilocin (the active metabolite of psilocybin) for diseases with high unmet medical needs, has obtained an interim order of the Supreme Court of British Colum...